
Global Gene Expression Market Growth, Size, Trends Analysis - By Product, By Technique, By Process, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
Description
Gene Expression Market Introduction and Overview
According to SPER market research, ‘Global Gene Expression Market Size- By Product, By Technique, By Process, By Application – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Gene Expression Market is predicted to reach 25.9 billion by 2034 with a CAGR of 5.26%.
Gene expression is the process by which a gene’s information is used to synthesise a functioning gene product, such as a protein or RNA molecule. These compounds are frequently required for the cell to function normally. During gene expression, a gene’s DNA sequence is replicated into a complementary RNA sequence, which is then used to control the manufacture of the matching protein or RNA molecule.
Restraints:
The rising costs of instruments and consumables in gene expression analysis create significant challenges for research and healthcare institutions. Complex technologies like microarrays and next-generation sequencing require advanced engineering and expensive reagents for RNA work, leading to high initial costs. Additionally, continuous research and development investments are needed to improve these technologies.
Scope of the report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered
By Product, By Technique, By Process, By Application
Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Companies Covered
QIAGEN, Quest Diagnostics, Inc, F. Hoffmann-La Roche Ltd, Illumina, Inc, PerkinElmer, Inc, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc, Agilent Technologies, GE Healthcare, Danaher Corp.
Global Gene Expression Market Segmentation:
By Product:
Based on the Product, Global Gene Expression Market is segmented as; Kits & Reagents, DNA Chips, Others.
By Technique:
Based on the Technique, Global Gene Expression Market is segmented as; RNA Expression, Promoter Analysis, Protein Expression & Posttranslational Modification Analysis.
By Process:
Based on the Process, Global Gene Expression Market is segmented as; Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation.
By Application:
Based on the Application, Global Gene Expression Market is segmented as; Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology, Others.
By Region:
This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.
According to SPER market research, ‘Global Gene Expression Market Size- By Product, By Technique, By Process, By Application – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Gene Expression Market is predicted to reach 25.9 billion by 2034 with a CAGR of 5.26%.
Gene expression is the process by which a gene’s information is used to synthesise a functioning gene product, such as a protein or RNA molecule. These compounds are frequently required for the cell to function normally. During gene expression, a gene’s DNA sequence is replicated into a complementary RNA sequence, which is then used to control the manufacture of the matching protein or RNA molecule.
Restraints:
The rising costs of instruments and consumables in gene expression analysis create significant challenges for research and healthcare institutions. Complex technologies like microarrays and next-generation sequencing require advanced engineering and expensive reagents for RNA work, leading to high initial costs. Additionally, continuous research and development investments are needed to improve these technologies.
Scope of the report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered
By Product, By Technique, By Process, By Application
Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Companies Covered
QIAGEN, Quest Diagnostics, Inc, F. Hoffmann-La Roche Ltd, Illumina, Inc, PerkinElmer, Inc, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc, Agilent Technologies, GE Healthcare, Danaher Corp.
Global Gene Expression Market Segmentation:
By Product:
Based on the Product, Global Gene Expression Market is segmented as; Kits & Reagents, DNA Chips, Others.
By Technique:
Based on the Technique, Global Gene Expression Market is segmented as; RNA Expression, Promoter Analysis, Protein Expression & Posttranslational Modification Analysis.
By Process:
Based on the Process, Global Gene Expression Market is segmented as; Sample Collection, Purification, cDNA synthesis & conversion, PCR Analysis, Data analysis & interpretation.
By Application:
Based on the Application, Global Gene Expression Market is segmented as; Drug Discovery & Development, Clinical Diagnostics, Biotech & Microbiology, Others.
By Region:
This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.
Table of Contents
- 1. Introduction
- 1.1.Scope of the report
- 1.2.Market segment analysis
- 2.Research Methodology
- 2.1.Research data source
- 2.1.1.Secondary Data
- 2.1.2.Primary Data
- 2.1.3.SPERs internal database
- 2.1.4.Premium insight from KOLs
- 2.2.Market size estimation
- 2.2.1.Top-down and Bottom-up approach
- 2.3.Data triangulation
- 3.Executive Summary
- 4.Market Dynamics
- 4.1.Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1.Drivers
- 4.1.2.Restraints
- 4.1.3.Opportunities
- 4.1.4.Challenges
- 5.Market variable and outlook
- 5.1.SWOT Analysis
- 5.1.1.Strengths
- 5.1.2.Weaknesses
- 5.1.3.Opportunities
- 5.1.4.Threats
- 5.2.PESTEL Analysis
- 5.2.1.Political Landscape
- 5.2.2.Economic Landscape
- 5.2.3.Social Landscape
- 5.2.4.Technological Landscape
- 5.2.5.Environmental Landscape
- 5.2.6.Legal Landscape
- 5.3.PORTERs Five Forces
- 5.3.1.Bargaining power of suppliers
- 5.3.2.Bargaining power of buyers
- 5.3.3.Threat of Substitute
- 5.3.4.Threat of new entrant
- 5.3.5.Competitive rivalry
- 5.4.Heat Map Analysis
- 6.Competitive Landscape
- 6.1.Global Gene Expression Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Gene Expression Market
- 7.Global Gene Expression Market, By Product (USD Million) 2021-2034
- 7.1.Kits & Reagents
- 7.2.DNA Chips
- 7.3.Others
- 8.Global Gene Expression Market, By Technique (USD Million) 2021-2034
- 8.1.RNA Expression
- 8.2.Promoter Analysis
- 8.3.Protein Expression & Posttranslational Modification Analysis
- 9.Global Gene Expression Market, By Process (USD Million) 2021-2034
- 9.1.Sample Collection
- 9.2.Purification
- 9.3.cDNA synthesis & conversion
- 9.4.PCR Analysis
- 9.5.Data analysis & interpretation
- 10.Global Gene Expression Market, By Application (USD Million) 2021-2034
- 10.1.Drug Discovery & Development
- 10.2.Clinical Diagnostics
- 10.3.Biotech & Microbiology
- 10.4.Others
- 11.Global Gene Expression Market, (USD Million) 2021-2034
- 11.1.Global Gene Expression Market Size and Market Share
- 12.Global Gene Expression Market, By Region, (USD Million) 2021-2034
- 12.1.Asia-Pacific
- 12.1.1.Australia
- 12.1.2.China
- 12.1.3.India
- 12.1.4.Japan
- 12.1.5.South Korea
- 12.1.6.Rest of Asia-Pacific
- 12.2.Europe
- 12.2.1.France
- 12.2.2.Germany
- 12.2.3.Italy
- 12.2.4.Spain
- 12.2.5.United Kingdom
- 12.2.6.Rest of Europe
- 12.3.Middle East and Africa
- 12.3.1.Kingdom of Saudi Arabia
- 12.3.2.United Arab Emirates
- 12.3.3.Qatar
- 12.3.4.South Africa
- 12.3.5.Egypt
- 12.3.6.Morocco
- 12.3.7.Nigeria
- 12.3.8.Rest of Middle-East and Africa
- 12.4.North America
- 12.4.1.Canada
- 12.4.2.Mexico
- 12.4.3.United States
- 12.5.Latin America
- 12.5.1.Argentina
- 12.5.2.Brazil
- 12.5.3.Rest of Latin America
- 13.Company Profile
- 13.1.Catalent Inc
- 13.1.1.Company details
- 13.1.2.Financial outlook
- 13.1.3.Product summary
- 13.1.4.Recent developments
- 13.2.QIAGEN
- 13.2.1.Company details
- 13.2.2.Financial outlook
- 13.2.3.Product summary
- 13.2.4.Recent developments
- 13.3.Quest Diagnostics, Inc
- 13.3.1.Company details
- 13.3.2.Financial outlook
- 13.3.3.Product summary
- 13.3.4.Recent developments
- 13.4.F. Hoffmann-La Roche Ltd
- 13.4.1.Company details
- 13.4.2.Financial outlook
- 13.4.3.Product summary
- 13.4.4.Recent developments
- 13.5.Illumina, Inc
- 13.5.1.Company details
- 13.5.2.Financial outlook
- 13.5.3.Product summary
- 13.5.4.Recent developments
- 13.6.PerkinElmer, Inc
- 13.6.1.Company details
- 13.6.2.Financial outlook
- 13.6.3.Product summary
- 13.6.4.Recent developments
- 13.7.Bio-Rad Laboratories
- 13.7.1.Company details
- 13.7.2.Financial outlook
- 13.7.3.Product summary
- 13.7.4.Recent developments
- 13.8.Thermo Fisher Scientific, Inc
- 13.8.1.Company details
- 13.8.2.Financial outlook
- 13.8.3.Product summary
- 13.8.4.Recent developments
- 13.9.Agilent Technologies
- 13.9.1.Company details
- 13.9.2.Financial outlook
- 13.9.3.Product summary
- 13.9.4.Recent developments
- 13.10.GE Healthcare
- 13.10.1.Company details
- 13.10.2.Financial outlook
- 13.10.3.Product summary
- 13.10.4.Recent developments
- 13.11.Danaher Corp.
- 13.11.1.Company details
- 13.11.2.Financial outlook
- 13.11.3.Product summary
- 13.11.4.Recent developments
- 13.12.Others
- 14.Conclusion
- 15.List of Abbreviations
- 16.Reference Links
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.